Mitral and aortic valvular disease associated with benfluorex use. - Université de Bretagne Occidentale Accéder directement au contenu
Article Dans Une Revue Journal of Heart Valve Disease Année : 2011

Mitral and aortic valvular disease associated with benfluorex use.

Résumé

Fenfluramine has been associated with an increased risk of pulmonary hypertension and valvular disease. Benfluorex is a fenfluramine derivative approved for the treatment of metabolic syndrome and type 2 diabetes mellitus. To date, only three isolated clinical cases of valvular disease and two recent case-control studies have been reported in patients exposed to benfluorex. Herein, the case is described of a patient with mitral and aortic valvular disease, with both echocardiographic and histopathological findings, who had been receiving benfluorex for several years, without any other etiology of valvular disease. The case is suggestive of toxic valvular lesions, similar to those observed previously during treatment with fenfluramine, pergolide, and cabergolide.
Fichier non déposé

Dates et versions

hal-00930669 , version 1 (14-01-2014)

Identifiants

  • HAL Id : hal-00930669 , version 1
  • PUBMED : 21714428

Citer

Yves Etienne, Yannick Jobic, Irene Frachon, Marjaneh Fatemi, Philippe Castellant, et al.. Mitral and aortic valvular disease associated with benfluorex use.. Journal of Heart Valve Disease, 2011, 20 (3), pp.348-50. ⟨hal-00930669⟩
46 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More